Today broker rating regarding NEA Column 1 0 Nearmap Price Target Raised 7.5% to A$0.86/Share by Canaccord Genuity
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025